5-(3-Chloro-4-methoxyphenyl)furfural - CAS 124014-00-2
Catalog: |
BB005783 |
Product Name: |
5-(3-Chloro-4-methoxyphenyl)furfural |
CAS: |
124014-00-2 |
Synonyms: |
5-(3-chloro-4-methoxyphenyl)furan-2-carbaldehyde |
IUPAC Name: | 5-(3-chloro-4-methoxyphenyl)furan-2-carbaldehyde |
Description: | 5-(3-Chloro-4-methoxyphenyl)furfural (CAS# 124014-00-2) is a useful research chemical. |
Molecular Weight: | 236.65 |
Molecular Formula: | C12H9ClO3 |
Canonical SMILES: | COC1=C(C=C(C=C1)C2=CC=C(O2)C=O)Cl |
InChI: | InChI=1S/C12H9ClO3/c1-15-12-4-2-8(6-10(12)13)11-5-3-9(7-14)16-11/h2-7H,1H3 |
InChI Key: | ZPFXNBOOLWTXFB-UHFFFAOYSA-N |
Boiling Point: | 387 °C at 760 mmHg |
Melting Point: | 128-130 °C (lit.) |
Purity: | 95 % |
Density: | 1.278 g/cm3 |
Appearance: | Solid |
Storage: | Sealed in dry, 2-8 °C |
MDL: | MFCD00582198 |
LogP: | 3.42110 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
KR-102114389-B1 | Novel sodium channel inhibitor compound, preparation method thereof, and pharmaceutical composition for prevention or treatment of sodium channel related diseases containing the same as an active ingredient | 20180502 |
KR-20190126525-A | Novel sodium channel inhibitor compound, preparation method thereof, and pharmaceutical composition for prevention or treatment of sodium channel related diseases containing the same as an active ingredient | 20180502 |
KR-101859074-B1 | Novel glycine amide compound or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for prevention or treatment of diseases induced by activation of sodium channel containing the same as an active ingredient | 20160128 |
KR-20170090547-A | Novel glycine amide compound or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for prevention or treatment of diseases induced by activation of sodium channel containing the same as an active ingredient | 20160128 |
KR-101591772-B1 | Novel amine compound or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for prevention or treatment of diseases induced by activation of T-type or N-type calcium ion channel containing the same as an active ingredient | 20131230 |
Complexity: | 246 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 236.0240218 |
Formal Charge: | 0 |
Heavy Atom Count: | 16 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 236.0240218 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 39.4 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3 |
-
Catalog: BB010056
(±)-cis-Cyclopentane-1,2-dicarboxylic acid
Detail
-
Catalog: BB036558
(+)-O,O'-Dibenzoyl-D-tartaric Acid Monohydrate
Detail
-
Catalog: BB032573
(-)-Carvone
Detail
-
Catalog: BB033577
(-)-2,3:4,6-Di-O-isopropylidene-2-keto-L-gulonic Acid Monohydrate
Detail
-
Catalog: BB015442
(±)-8a-Methyl-3,4,8,8a-tetrahydro-1,6(2H,7H)-naphthalenedione
Detail
-
Catalog: BB031901
(-)-Diisopropyl D-Tartrate
Detail
-
Catalog: BB009173
(+/-)-trans-Oxirane-2,3-dicarboxylic acid
Detail
-
Catalog: BB012630
(+)-Dibenzoyl-D-tartaric Acid
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS